|
humans |
74 |
|
interprofessional education |
70 |
|
female |
54 |
|
traditional chinese medicine |
51 |
|
apoptosis |
49 |
|
chinese medicine |
44 |
|
acupuncture |
42 |
|
male |
42 |
|
social interaction anxiety |
40 |
|
depression |
38 |
|
adult |
37 |
|
animals |
31 |
|
oxidative stress |
30 |
|
breast cancer |
28 |
|
partnership model |
28 |
|
hepatocellular carcinoma |
26 |
|
herbal medicine |
25 |
|
rats |
25 |
|
berberine |
23 |
|
hong kong |
23 |
|
insomnia |
23 |
|
randomized controlled trial |
23 |
|
chinese herbal medicine |
22 |
|
covid-19 |
22 |
|
apoptosis - drug effects |
21 |
|
meta-analysis |
21 |
|
middle aged |
21 |
|
polysaccharides |
21 |
|
pregnancy |
21 |
|
rats, sprague-dawley |
21 |
|
inflammation |
20 |
|
quality of life |
20 |
|
colorectal cancer |
18 |
|
cytokines |
18 |
|
medical sciences |
18 |
|
menopause |
18 |
|
neuroprotection |
18 |
|
phytotherapy |
18 |
|
chinese |
17 |
|
network pharmacology |
17 |
|
polycystic ovary syndrome |
17 |
|
adult learning principles |
16 |
|
collaborative practice |
16 |
|
construct validation |
16 |
|
dendrobium officinale |
16 |
|
diabetes |
16 |
|
electroacupuncture |
16 |
|
evaluation |
16 |
|
medicine, chinese traditional |
16 |
|
osteoporosis |
16 |
|
rct |
16 |
|
review |
16 |
|
achievement emotions |
15 |
|
acupressure |
15 |
|
autophagy |
15 |
|
cancer |
15 |
|
cell line |
15 |
|
clinical trial |
15 |
|
cytotoxicity |
15 |
|
metastasis |
15 |
|
nf-κb |
15 |
|
placebo |
15 |
|
reactive oxygen species |
15 |
|
sjogren's syndrome |
15 |
|
adolescent |
14 |
|
beta-amyloid |
14 |
|
chinese women |
14 |
|
dose-response relationship, drug |
14 |
|
gene expression regulation - drug effects |
14 |
|
obesity |
14 |
|
pharmacokinetics |
14 |
|
systematic review |
14 |
|
time factors |
14 |
|
treatment outcome |
14 |
|
anti-cancer |
13 |
|
aquaporin 5 |
13 |
|
cell line, tumor |
13 |
|
clinical trials |
13 |
|
diabetic nephropathy |
13 |
|
erxian decoction |
13 |
|
medicinal plants |
13 |
|
misoprostol |
13 |
|
ovulation induction |
13 |
|
plant extracts - pharmacology |
13 |
|
superoxide dismutase |
13 |
|
anxiety |
12 |
|
autoantibodies |
12 |
|
caveolin-1 |
12 |
|
cells, cultured |
12 |
|
cluster analysis |
12 |
|
drug discovery |
12 |
|
dysglycaemia |
12 |
|
gut microbiota |
12 |
|
human spermatozoa |
12 |
|
ischemic stroke |
12 |
|
mental health |
12 |
|
mice |
12 |
|
mifepristone |
12 |
|
nitric oxide |
12 |
|
sleep |
12 |
|
stress |
12 |
|
validation |
12 |
|
5-fluorouracil |
11 |
|
alzheimer's disease |
11 |
|
animal experiment |
11 |
|
cell proliferation - drug effects |
11 |
|
chemobrain |
11 |
|
chemotherapy |
11 |
|
coptidis rhizoma aqueous extract |
11 |
|
diagnosis |
11 |
|
diet therapy |
11 |
|
differentiation |
11 |
|
drugs, chinese herbal - pharmacology - therapeutic use |
11 |
|
enzyme inhibitors - pharmacology |
11 |
|
fertilization |
11 |
|
healthcare students |
11 |
|
herbal medicines |
11 |
|
infertility |
11 |
|
interprofessional collaboration |
11 |
|
medicine |
11 |
|
mitochondrial dysfunction |
11 |
|
pain |
11 |
|
person-centred analysis |
11 |
|
plants, medicinal - chemistry |
11 |
|
qigong |
11 |
|
reactive oxygen species - metabolism |
11 |
|
ros |
11 |
|
sars-cov-2 |
11 |
|
self-acupressure |
11 |
|
self-help |
11 |
|
vegf |
11 |
|
angiogenesis |
10 |
|
antigen-presentation |
10 |
|
antineoplastic agents - pharmacology |
10 |
|
asian continental ancestry group |
10 |
|
bioavailability |
10 |
|
carbon tetrachloride |
10 |
|
cell migration |
10 |
|
coptidis rhizoma |
10 |
|
cytokine and chemokine response |
10 |
|
diabetic retinopathy |
10 |
|
drugs, chinese herbal - therapeutic use |
10 |
|
fallopian tube |
10 |
|
fertilization in vitro |
10 |
|
in vitro fertilization |
10 |
|
mers-cov |
10 |
|
parkinson's disease |
10 |
|
pathogenesis |
10 |
|
polysaccharide |
10 |
|
pragmatic |
10 |
|
pregnancy rate |
10 |
|
prospective studies |
10 |
|
quality control |
10 |
|
sars-cov |
10 |
|
sjögren's syndrome |
10 |
|
spermatozoa |
10 |
|
stroke |
10 |
|
viral replication |
10 |
|
acrosome reaction |
9 |
|
analgesia |
9 |
|
antioxidant |
9 |
|
bdnf |
9 |
|
chinese medicines |
9 |
|
collaboration perception |
9 |
|
cryopreservation |
9 |
|
fallopian tubes - metabolism |
9 |
|
ferroptosis |
9 |
|
health professions education |
9 |
|
health sciences |
9 |
|
hyperprolactinemia |
9 |
|
hypoxia |
9 |
|
integrative medicine |
9 |
|
interprofessional identity |
9 |
|
intervention |
9 |
|
intimate partner violence |
9 |
|
levonorgestrel |
9 |
|
medical education |
9 |
|
mitochondria |
9 |
|
mtor |
9 |
|
muscular contraction |
9 |
|
nursing |
9 |
|
peroxynitrite |
9 |
|
pharmacy |
9 |
|
prognosis |
9 |
|
self-administered acupressure |
9 |
|
undergraduate students |
9 |
|
adrenomedullin - genetics - metabolism |
8 |
|
appswe/ps1de9 |
8 |
|
aquaporin 5 - metabolism |
8 |
|
aquaporin 9 |
8 |
|
b-cell suppression |
8 |
|
calcitonin receptor-like protein |
8 |
|
cancer stem cells |
8 |
|
cancer therapy |
8 |
|
celastrol |
8 |
|
cell communication - physiology |
8 |
|
chronic obstructive pulmonary disease |
8 |
|
cilia - metabolism - physiology |
8 |
|
complementary medicine |
8 |
|
confirmatory factor analysis |
8 |
|
dendrobium |
8 |
|
diagnosis, differential |
8 |
|
embryo transfer |
8 |
|
enzyme-linked immunosorbent assay |
8 |
|
epithelium - metabolism - physiology |
8 |
|
estradiol - blood |
8 |
|
estrogen receptor |
8 |
|
family caregivers |
8 |
|
fibrosis |
8 |
|
frozen-thawed embryo transfer |
8 |
|
glycoproteins - physiology |
8 |
|
herb medicine |
8 |
|
hong kong - epidemiology |
8 |
|
hormones - metabolism - pharmacology |
8 |
|
interleukin-6 |
8 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
|
invasion |
8 |
|
ivf |
8 |
|
letrozole |
8 |
|
maternal age |
8 |
|
mechanism |
8 |
|
membrane proteins - genetics - metabolism |
8 |
|
menstrual cycle - genetics - metabolism - physiology |
8 |
|
metabolomics |
8 |
|
mir-23a |
8 |
|
mitochondria - drug effects - metabolism |
8 |
|
models, biological |
8 |
|
mouse model |
8 |
|
natural products |
8 |
|
ovarian stimulation |
8 |
|
oxidative stress - drug effects |
8 |
|
pregnancy outcome |
8 |
|
proliferation |
8 |
|
receptor activity-modifying proteins |
8 |
|
receptors, calcitonin - genetics - metabolism |
8 |
|
recurrence |
8 |
|
seeds |
8 |
|
spermatozoa - metabolism - physiology |
8 |
|
t cells |
8 |
|
tumor microenvironment |
8 |
|
type 2 diabetes mellitus |
8 |
|
ulipristal acetate |
8 |
|
young adult |
8 |
|
acteoside |
7 |
|
age |
7 |
|
age‐specific reference range |
7 |
|
alanine aminotransferase |
7 |
|
ampk |
7 |
|
anti-mullerian hormone |
7 |
|
antimetastasis |
7 |
|
anti‐müllerian hormone |
7 |
|
antral follicle count |
7 |
|
application |
7 |
|
aqp5 |
7 |
|
aspartate aminotransferase |
7 |
|
autoimmune diseases |
7 |
|
automated chemiluminescence assay |
7 |
|
berberine - administration & dosage - pharmacology |
7 |
|
berberine - pharmacology - therapeutic use |
7 |
|
bioactive compounds |
7 |
|
body weight |
7 |
|
breg cells |
7 |
|
cell movement - drug effects |
7 |
|
chemiluminescence |
7 |
|
chromatography, high pressure liquid |
7 |
|
complementary and alternative medicine |
7 |
|
coping |
7 |
|
coptis - chemistry |
7 |
|
counseling |
7 |
|
culture |
7 |
|
disease models, animal |
7 |
|
dopamine |
7 |
|
drug-induced liver injury - prevention and control |
7 |
|
drugs, chinese herbal - pharmacology |
7 |
|
emergency contraception |
7 |
|
endometrium |
7 |
|
estrogen receptors (ers) |
7 |
|
extraction |
7 |
|
fatigue |
7 |
|
flavonoids |
7 |
|
g2 arrest |
7 |
|
g2 phase - drug effects |
7 |
|
genipin |
7 |
|
geriatrics |
7 |
|
glycodelin |
7 |
|
green tea |
7 |
|
health economic analysis |
7 |
|
healthcare education |
7 |
|
hepatotoxicity |
7 |
|
hkuot-s2 protein |
7 |
|
homozygote |
7 |
|
il-10 |
7 |
|
integrative body-mind-spirit (ibms) |
7 |
|
lignans |
7 |
|
liver - drug effects - pathology |
7 |
|
liver histopathology |
7 |
|
major depressive disorder |
7 |
|
microrna |
7 |
|
mitophagy |
7 |
|
morphine consumption |
7 |
|
motility |
7 |
|
multiple reaction monitoring |
7 |
|
multiple sclerosis |
7 |
|
nasopharyngeal neoplasms |
7 |
|
neoplasm invasiveness |
7 |
|
neoplasm metastasis |
7 |
|
nitric oxide synthase |
7 |
|
osteoblast functions |
7 |
|
ovarian response |
7 |
|
ovarian sensitivity index |
7 |
|
ovariectomy (ovx) |
7 |
|
oviductal epithelial cell |
7 |
|
pcr |
7 |
|
pi3k/akt |
7 |
|
poor ovarian response |
7 |
|
prevalence |
7 |
|
proanthocyanidins |
7 |
|
questionnaires |
7 |
|
rho gtp-binding proteins - antagonists & inhibitors - metabolism |
7 |
|
rho gtpases |
7 |
|
risk factor |
7 |
|
safety |
7 |
|
self-renewal |
7 |
|
self‐administered acupressure |
7 |
|
sleep disturbance |
7 |
|
t follicular helper cells |
7 |
|
tumor |
7 |
|
tumor growth inhibition |
7 |
|
tumor‐shrinking decoction |
7 |
|
ultra‐pressure liquid chromatography coupled tandem mass spectrometry |
7 |
|
vascular endothelial growth factor |
7 |
|
wnt proteins - physiology |
7 |
|
zona pellucida |
7 |
|
acupoint |
6 |
|
adrenomedullin |
6 |
|
advanced glycation end-products |
6 |
|
adverse events |
6 |
|
aged |
6 |
|
akt |
6 |
|
albuminuria |
6 |
|
animal bile |
6 |
|
anoxia - metabolism |
6 |
|
antineoplastic agents, phytogenic - pharmacology |
6 |
|
antioxidant activity |
6 |
|
antioxidants - analysis - metabolism |
6 |
|
antioxidation |
6 |
|
aquaporin-5 |
6 |
|
arctium - chemistry - genetics - metabolism |
6 |
|
baicalin |
6 |
|
bcl-2/beclin-1 |
6 |
|
benzodiazepine discontinuation |
6 |
|
bile acids |
6 |
|
burdock |
6 |
|
cachexia |
6 |
|
caffeoylquinic acids |
6 |
|
cancer diagnosis |
6 |
|
cancer management |
6 |
|
cancer metastasis |
6 |
|
capacitation |
6 |
|
caregiver stress |
6 |
|
caspase 3 - metabolism |
6 |
|
cell cycle |
6 |
|
cell invasion |
6 |
|
cell-signaling pathways |
6 |
|
cellular neuroscience |
6 |
|
cerebral ischemia |
6 |
|
chemical constituent |
6 |
|
chemoprevention |
6 |
|
chinese medicine formula |
6 |
|
chromosome deletion |
6 |
|
chronic kidney disease |
6 |
|
colon cancer |
6 |
|
cytotoxic activity |
6 |
|
dendrobium - chemistry |
6 |
|
dendrobium officinale polysaccharides |
6 |
|
diabetes & endocrinology |
6 |
|
diabetic kidney disease |
6 |
|
diabetic nephropathy & vascular disease |
6 |
|
drug resistance |
6 |
|
efficacy |
6 |
|
eg-vegf |
6 |
|
electron spin resonance spectroscopy - methods |
6 |
|
embryo, mammalian |
6 |
|
endocrinology pharmacy and pharmacology |
6 |
|
er-xian decoction |
6 |
|
erk1/2 |
6 |
|
experimental autoimmune encephalomyelitis |
6 |
|
extracellular matrix proteins - physiology |
6 |
|
f-actin |
6 |
|
fallopian tubes - cytology - metabolism |
6 |
|
fasting glucose |
6 |
|
follow-up studies |
6 |
|
fructus lycii |
6 |
|
gallbladder |
6 |
|
gallic acid |
6 |
|
gardenia |
6 |
|
gegen qinlian decoction |
6 |
|
genotype |
6 |
|
gestational age |
6 |
|
gleditsia sinensis |
6 |
|
glomerular filtration rate |
6 |
|
glutathione peroxidase |
6 |
|
he-ying-qing-re formula |
6 |
|
health-related quality of life |
6 |
|
high performance liquid chromatography-evaporative light scattering detector system |
6 |
|
ht-29 cells |
6 |
|
immune response |
6 |
|
immunization |
6 |
|
immunomodulation |
6 |
|
intestinal mucositis |
6 |
|
intracytoplasmic sperm injection |
6 |
|
iridoid glycosides |
6 |
|
iridoids |
6 |
|
isoliquiritigenin |
6 |
|
lc-ms |
6 |
|
leguminosae |
6 |
|
lignans - analysis - metabolism |
6 |
|
logistic models |
6 |
|
maldi-qit-tof ms |
6 |
|
mechanisms |
6 |
|
medical abortion |
6 |
|
menotropins - therapeutic use |
6 |
|
metabolic syndrome |
6 |
|
metabolism |
6 |
|
metformin |
6 |
|
mice, inbred c57bl |
6 |
|
micrornas |
6 |
|
migration |
6 |
|
molecular neuroscience |
6 |
|
morphology |
6 |
|
mucin-5ac |
6 |
|
naringin |
6 |
|
nephrology |
6 |
|
neurogenesis |
6 |
|
neuroscience |
6 |
|
obstetrics and gynecology medical sciences |
6 |
|
olfactomedin-1 |
6 |
|
oocyte retrieval |
6 |
|
oral glucose tolerance test |
6 |
|
osmolar concentration |
6 |
|
outcome assessment (health care) |
6 |
|
oxymatrine |
6 |
|
p-pkb |
6 |
|
p53 |
6 |
|
parkinson’s disease |
6 |
|
pc12 cells |
6 |
|
peptides |
6 |
|
phytochemical |
6 |
|
pkr1 |
6 |
|
pkr2 |
6 |
|
plant extracts - analysis - metabolism |
6 |
|
plant roots - chemistry - genetics - metabolism |
6 |
|
polymerase chain reaction |
6 |
|
pomegranate peel ellagitannins |
6 |
|
pregnancy - blood |
6 |
|
pregnancy, tubal - physiopathology |
6 |
|
progesterone |
6 |
|
progesterone receptor |
6 |
|
quinic acid - analogs & derivatives - analysis - metabolism |
6 |
|
random allocation |
6 |
|
randomized controlled trial (rct) |
6 |
|
randomized controlled trials |
6 |
|
retrospective studies |
6 |
|
risk factors |
6 |
|
ro/rock signaling |
6 |
|
roots |
6 |
|
seeds - chemistry - genetics - metabolism |
6 |
|
sham |
6 |
|
signal transduction - drug effects |
6 |
|
sleep hygiene |
6 |
|
soluble receptor of advanced glycation end-products |
6 |
|
sperm fucosyltransferase-5 |
6 |
|
sperm injections, intracytoplasmic |
6 |
|
sperm motility |
6 |
|
steroid receptors |
6 |
|
steroidogenic |
6 |
|
structural identification |
6 |
|
tnf-α |
6 |
|
tubal ectopic pregnancy |
6 |
|
uncaria rhynchophylla |
6 |
|
up-regulation - physiology |
6 |
|
utmvec-myo |
6 |
|
withdrawal |
6 |
|
wnt signaling |
6 |
|
zona pellucida binding |
6 |
|
25-hydroxyvitamin d |
5 |
|
a-253 |
5 |
|
abortion, induced - methods |
5 |
|
active components |
5 |
|
adipocyte |
5 |
|
adipocytes - metabolism |
5 |
|
adiponectin - biosynthesis - metabolism |
5 |
|
adiponectin and adipokine |
5 |
|
adiposity |
5 |
|
adverse drug reaction |
5 |
|
aging |
5 |
|
amino acid sequence |
5 |
|
androgen |
5 |
|
angiopoietin |
5 |
|
anti-inflammatory |
5 |
|
anti-mullerian hormone - blood |
5 |
|
anti-müllerian hormone |
5 |
|
antigens, cd - genetics - metabolism |
5 |
|
antigens, differentiation, myelomonocytic - genetics - metabolism |
5 |
|
antipsychotic agents - administration and dosage - therapeutic use |
5 |
|
antipsychotics |
5 |
|
antitumorigenicity |
5 |
|
anti‐mullerian hormone |
5 |
|
aquaporin-5 (aqp-5) |
5 |
|
assisted reproduction |
5 |
|
assisted reproductive technologies |
5 |
|
auricular acupressure |
5 |
|
authentication |
5 |
|
base sequence |
5 |
|
bcl-2-associated x protein - metabolism |
5 |
|
benzofurans - pharmacology |
5 |
|
bile - chemistry |
5 |
|
bioactivity-guided fractionation |
5 |
|
biochemical profile |
5 |
|
biological markers - blood |
5 |
|
birth control medical sciences |
5 |
|
blood-brain barrier |
5 |
|
blotting, western |
5 |
|
body-mind-spirit |
5 |
|
brain |
5 |
|
cancer cell culture |
5 |
|
cancer chemotherapy |
5 |
|
cardiomyocytes |
5 |
|
casa |
5 |
|
cell motility |
5 |
|
cell viability |
5 |
|
chemotherapy-associated insomnia |
5 |
|
china |
5 |
|
chinese herbal antioxidants |
5 |
|
chinese medicinal formula |
5 |
|
cholagogues and choleretics - pharmacology - therapeutic use |
5 |
|
choristoma - metabolism - pathology |
5 |
|
chronic diseases |
5 |
|
chronic pain |
5 |
|
ciliary beat |
5 |
|
circulating tumor cells |
5 |
|
constituent fractions |
5 |
|
cumulus oophorus |
5 |
|
cytokine storm |
5 |
|
cytoprotection |
5 |
|
dendrobium candidum |
5 |
|
dna damage |
5 |
|
dna microarray |
5 |
|
double-blind method |
5 |
|
down syndrome |
5 |
|
down syndrome - blood |
5 |
|
drug combinations |
5 |
|
drug evaluation, preclinical |
5 |
|
drug interactions |
5 |
|
drug therapy, combination |
5 |
|
edible plants |
5 |
|
embryo cryopreservation |
5 |
|
embryo implantation |
5 |
|
embryo implantation - genetics |
5 |
|
embryo research - legislation & jurisprudence |
5 |
|
endocrine glands |
5 |
|
endometrial attachment |
5 |
|
endometrial receptivity |
5 |
|
endometriosis |
5 |
|
endometriosis - metabolism - pathology |
5 |
|
endometrium - cytology - metabolism |
5 |
|
endometrium - drug effects - metabolism |
5 |
|
endoplasmic reticulum stress |
5 |
|
energy metabolism |
5 |
|
estrogen |
5 |
|
etoposide |
5 |
|
extracellular signal-regulated map kinases - genetics - metabolism |
5 |
|
fabaceae - chemistry |
5 |
|
facemask |
5 |
|
fertility preservation |
5 |
|
ficus virens |
5 |
|
flavonoid |
5 |
|
flow cytometry |
5 |
|
follicle stimulating hormone - blood |
5 |
|
frailty |
5 |
|
frozen embryo transfer |
5 |
|
fucosyltransferase |
5 |
|
functional food |
5 |
|
fusion |
5 |
|
galectin-3 |
5 |
|
glycoproteins - genetics - metabolism |
5 |
|
glycyrrhizin |
5 |
|
gonadotrophin dosing |
5 |
|
gut microbiome |
5 |
|
gut–liver axis |
5 |
|
hcg |
5 |
|
heme oxygenase 1 |
5 |
|
heme oxygenase-1 |
5 |
|
heme oxygenase-1 - genetics - metabolism |
5 |
|
hepatic stellate cell |
5 |
|
herb-drug interactions - physiology |
5 |
|
herbal interactions |
5 |
|
holistic |
5 |
|
hot flushes |
5 |
|
human fallopian tube |
5 |
|
human trophoblast |
5 |
|
hydrogen peroxide - toxicity |
5 |
|
hydrogen-ion concentration |
5 |
|
id-1 |
5 |
|
immunoassay |
5 |
|
immunohistochemistry |
5 |
|
immunotherapy |
5 |
|
implantation |
5 |
|
in vitro fertilsation |
5 |
|
in-vitro fertilization |
5 |
|
injections, intramuscular |
5 |
|
inos |
5 |
|
insulin resistance |
5 |
|
intercellular signaling peptides and proteins - biosynthesis |
5 |
|
international students |
5 |
|
interprofessional attitudes |
5 |
|
intestinal absorption |
5 |
|
ire1α |
5 |
|
ishikawa cell line |
5 |
|
knee osteoarthritis |
5 |
|
labial gland |
5 |
|
laser-captured microdissection |
5 |
|
leukotriene b4-12-hydroxydehydrogenase |
5 |
|
lipid metabolism |
5 |
|
liver cancer |
5 |
|
liver diseases |
5 |
|
liver fibrosis |
5 |
|
lymph node metastatic carcinoma |
5 |
|
lysosomal proteolysis |
5 |
|
m3 mucarinic acetylcholine receptor |
5 |
|
machine learning |
5 |
|
macrophage polarization |
5 |
|
massage |
5 |
|
matrix metalloproteinase |
5 |
|
matrix metalloproteinases |
5 |
|
medicine, chinese traditional - adverse effects - utilization |
5 |
|
menstrual cycle |
5 |
|
microarray |
5 |
|
mild cognitive impairment |
5 |
|
mir-21 |
5 |
|
miscarriage |
5 |
|
models, neurological |
5 |
|
molecular sequence data |
5 |
|
mucositis |
5 |
|
mutation |
5 |
|
nafld |
5 |
|
nanoparticles |
5 |
|
nascent protein synthesis |
5 |
|
natural cycle |
5 |
|
natural cycles |
5 |
|
natural product |
5 |
|
neuroinflammation |
5 |
|
neuroplasticity |
5 |
|
neuroprotective agents - pharmacology |
5 |
|
neurotoxicity syndromes - drug therapy |
5 |
|
neurotoxins |
5 |
|
ng-nitroarginine methyl ester - pharmacology |
5 |
|
nitric oxide synthase - antagonists & inhibitors |
5 |
|
non-alcoholic fatty liver disease |
5 |
|
non-small cell lung cancer |
5 |
|
novel approach |
5 |
|
observer variation |
5 |
|
obstetric/gynecology patients |
5 |
|
obstetrics and gynecology |
5 |
|
online interprofessional education |
5 |
|
oocyte cryopreservation |
5 |
|
orchidaceae |
5 |
|
organ protection |
5 |
|
organotherapy |
5 |
|
ovarian response prediction index |
5 |
|
ovarian stromal blood flow |
5 |
|
ovulation induction - adverse effects |
5 |
|
ovulation induction - adverse effects - methods |
5 |
|
ovulation induction - methods |
5 |
|
parkinson disease - drug therapy |
5 |
|
peony-glycyrrhiza decoction (pgd) |
5 |
|
pk1 |
5 |
|
placebos |
5 |
|
placentation - drug effects - physiology |
5 |
|
plant extracts - pharmacology - therapeutic use |
5 |
|
plant extracts - therapeutic use |
5 |
|
plant preparations - therapeutic use |
5 |
|
plasminogen activator inhibitor 1 - biosynthesis |
5 |
|
post-traumatic stress disorder |
5 |
|
predictive value of tests |
5 |
|
pregnancy proteins - physiology |
5 |
|
pregnancy trimester, first |
5 |
|
pregnancy trimester, second |
5 |
|
preimplantation diagnosis |
5 |
|
prejudiced attitudes |
5 |
|
premature ovarian failure |
5 |
|
prenatal diagnosis |
5 |
|
primary carcinoma |
5 |
|
primary endometrial cell culture |
5 |
|
progesterone elevation |
5 |
|
protocol |
5 |
|
psychological abuse |
5 |
|
psychosocial intervention |
5 |
|
qi |
5 |
|
radix salviae miltiorrhizae |
5 |
|
randomized controlled trials as topic |
5 |
|
reproducibility of results |
5 |
|
reproductive techniques, assisted - ethics - legislation & jurisprudence - standards |
5 |
|
research |
5 |
|
rhizoma chuanxiong |
5 |
|
saliva - metabolism - secretion |
5 |
|
salivary glands - drug effects - metabolism |
5 |
|
saponins |
5 |
|
schizophrenia - drug therapy - epidemiology |
5 |
|
semen |
5 |
|
sensitivity and specificity |
5 |
|
sham acupuncture |
5 |
|
side effects |
5 |
|
signaling pathway |
5 |
|
sinew acupuncture |
5 |
|
sjögren's syndrome (ss) |
5 |
|
smad7 |
5 |
|
socioeconomic factors |
5 |
|
sperm cryopreservation |
5 |
|
sperm function |
5 |
|
spheroids |
5 |
|
standard chemicals |
5 |
|
stimulated cycles |
5 |
|
sublingual |
5 |
|
systemic lupus erythematosus |
5 |
|
t follicular helper |
5 |
|
tcm |
5 |
|
testosterone - blood |
5 |
|
tetrandrine |
5 |
|
therapeutic potential |
5 |
|
three-dimensional ultrasound |
5 |
|
tian xian liquid |
5 |
|
timosaponin aiii |
5 |
|
topoisomerase 1 |
5 |
|
trigeminal nerve stimulation |
5 |
|
trophoblast |
5 |
|
trophoblasts - metabolism |
5 |
|
tumour-associated macrophage |
5 |
|
united kingdom |
5 |
|
university students |
5 |
|
urokinase plasminogen activator |
5 |
|
vaginal misoprostol |
5 |
|
vascular endothelial growth factor, endocrine-gland-derived - biosynthesis |
5 |
|
virus infection |
5 |
|
vitamin d |
5 |
|
wnt-signaling |
5 |
|
xiap |
5 |
|
α-secretases |
5 |
|
β-secretases |
5 |
|
abnormal vascular bundle |
4 |
|
abortifacient agents, nonsteroidal - administration & dosage - adverse effects |
4 |
|
abortifacient agents, nonsteroidal - pharmacokinetics |
4 |
|
abortion, induced |
4 |
|
abuse assessment screen |
4 |
|
ace2 |
4 |
|
acetic acid |
4 |
|
acetic acid - pharmacokinetics |
4 |
|
acrosome reaction - drug effects - physiology |
4 |
|
activity-based sensing |
4 |
|
acupuncture analgesia |
4 |
|
acupuncture points |
4 |
|
adenosine triphosphate - metabolism |
4 |
|
adhesions |
4 |
|
adiponectin |
4 |
|
adipor |
4 |
|
adrenomedullin - pharmacology |
4 |
|
adult neurogenesis |
4 |
|
adulterant |
4 |
|
afc |
4 |
|
afp |
4 |
|
age factors |
4 |
|
akt/mtor |
4 |
|
alcoholic liver injury |
4 |
|
algorithms |
4 |
|
alleles |
4 |
|
alpha-fetoprotein |
4 |
|
alpha-thalassemia - diagnosis - embryology - genetics |
4 |
|
alpha-thalassemia - diagnosis - genetics |
4 |
|
amniotic fluid |
4 |
|
amyloid beta-peptides - toxicity |
4 |
|
androgen receptor |
4 |
|
angiosperms |
4 |
|
anti-aging |
4 |
|
anti-angiogenesis |
4 |
|
anti-microbial |
4 |
|
anti-mullerian hormone - analysis - blood |
4 |
|
anti-möllerian hormone |
4 |
|
anti-obesity drugs |
4 |
|
anti-oxidation |
4 |
|
anti-oxidative |
4 |
|
antidepressive agents |
4 |
|
antimullerian hormone |
4 |
|
antioxidants |
4 |
|
aromatase |
4 |
|
art |
4 |
|
arthritis |
4 |
|
artificial intelligence |
4 |
|
asians |
4 |
|
assessment |
4 |
|
asthenozoospermia - metabolism - pathology |
4 |
|
astragalus |
4 |
|
atrial fibrillation |
4 |
|
attachment |
4 |
|
attitude |
4 |
|
auricular acupoint |
4 |
|
auricular acupuncture |
4 |
|
automated chemiluminescence |
4 |
|
b cells |
4 |
|
battered women - statistics and numerical data |
4 |
|
bcl-2-associated x protein - biosynthesis |
4 |
|
behavior, animal |
4 |
|
beige cell |
4 |
|
berberine - pharmacology - toxicity |
4 |
|
beta-thalassemia - diagnosis - genetics |
4 |
|
bioinformatics analysis |
4 |
|
biological response fingerprinting |
4 |
|
biology |
4 |
|
biomarker |
4 |
|
blastomere |
4 |
|
blastomeres |
4 |
|
blastula - metabolism |
4 |
|
blind source separation |
4 |
|
bologna criteria |
4 |
|
botanical drug products |
4 |
|
brain ischemia - physiopathology |
4 |
|
c-fos |
4 |
|
cag repeat |
4 |
|
calcitonin gene-related peptide - pharmacology |
4 |
|
carbonyl cyanide p-trifluoromethoxyphenylhydrazone - pharmacology |
4 |
|
cardioprotection |
4 |
|
case-control studies |
4 |
|
caveolin 1 - genetics - metabolism |
4 |
|
caveolin 1 - metabolism |
4 |
|
cell differentiation - genetics - physiology |
4 |
|
cell proliferation |
4 |
|
cell transformation, neoplastic - drug effects - metabolism |
4 |
|
cessation rate of sleeping medications |
4 |
|
chemokine cxcl10 - metabolism |
4 |
|
child abuse - psychology - statistics & numerical data |
4 |
|
child abuse and neglect |
4 |
|
child, preschool |
4 |
|
chinese culture |
4 |
|
chinese medicinal herbs |
4 |
|
chorionic gonadotropin - therapeutic use |
4 |
|
chorionic gonadotropin, beta subunit, human - blood |
4 |
|
chromosome, human, y |
4 |
|
chrysotoxine |
4 |
|
cigarette smoke |
4 |
|
ciliary beat frequency |
4 |
|
cohort studies |
4 |
|
combined injectable contraceptive |
4 |
|
combined oral contraceptive |
4 |
|
comparative study |
4 |
|
complementary and alternative medicines |
4 |
|
contraceptives, oral, combined - pharmacology |
4 |
|
control |
4 |
|
controlled ovarian stimulation |
4 |
|
coptidis rhizome aqueous extract |
4 |
|
cost-benefit analysis |
4 |
|
counselling |
4 |
|
creb |
4 |
|
cricetinae |
4 |
|
cumulative live birth |
4 |
|
cumulative live-birth |
4 |
|
cumulus cells - physiology |
4 |
|
curcuma longa |
4 |
|
curcumin |
4 |
|
cyclin d1 |
4 |
|
cyclooctanes - pharmacology |
4 |
|
cytokine |
4 |
|
cytokines - biosynthesis |
4 |
|
d2 receptors |
4 |
|
deletion |
4 |
|
depression, postpartum - epidemiology - psychology |
4 |
|
development |
4 |
|
dhea |
4 |
|
dibenzocyclooctadiene lignans |
4 |
|
dilution linearity |
4 |
|
dioscorea protein |
4 |
|
dioxoles |
4 |
|
dna fragmentation - drug effects |
4 |
|
dna, mitochondrial - genetics - isolation & purification |
4 |
|
dna, mitochondrial - metabolism |
4 |
|
dnmt1 |
4 |
|
doppler |
4 |
|
down syndrome - blood - diagnosis |
4 |
|
down's syndrome |
4 |
|
down-regulation |
4 |
|
drugs, chinese herbal |
4 |
|
drugs, chinese herbal - adverse effects - pharmacology - therapeutic use |
4 |
|
drugs, chinese herbal - standards |
4 |
|
egfr |
4 |
|
electron paramagnetic resonance |
4 |
|
embryo culture techniques |
4 |
|
embryonic development |
4 |
|
emt |
4 |
|
endocrinology |
4 |
|
endometrial and subendometrial vascularity |
4 |
|
endometrial injury |
4 |
|
endometrium - metabolism |
4 |
|
entry inhibitor |
4 |
|
erp57 |
4 |
|
estradiol |
4 |
|
estradiol and menopause |
4 |
|
estrogen-stimulating protein |
4 |
|
eukaryotic elongation factor 2 |
4 |
|
experimental sjögren’s syndrome |
4 |
|
extracellular matrix - physiology |
4 |
|
extracellular matrix proteins - chemistry - genetics - metabolism |
4 |
|
extracellular signal regulated kinase |
4 |
|
extracellular vesicles |
4 |
|
family characteristics |
4 |
|
family planning service provision |
4 |
|
female reproductive tract |
4 |
|
fertility |
4 |
|
fet |
4 |
|
fibroblasts - drug effects - metabolism |
4 |
|
first trimester |
4 |
|
follicle |
4 |
|
follicle stimulating hor mone/administration & dosage |
4 |
|
follicle stimulating hormone/therapeutic use |
4 |
|
follicular fluid |
4 |
|
foods |
4 |
|
forecasting |
4 |
|
free radical |
4 |
|
freeze-thaw stability |
4 |
|
gardenia jasminoides ellis |
4 |
|
gender ratio |
4 |
|
gender selection |
4 |
|
gene regulation |
4 |
|
genes, plant |
4 |
|
genetic predisposition to disease |
4 |
|
ginsenoside rg1 |
4 |
|
glutamate |
4 |
|
glycoproteins - chemistry - genetics - metabolism |
4 |
|
gonadotropins/administration & dosage |
4 |
|
gonadotropins/therapeutic use |
4 |
|
granulocytic‐myeloid‐derived suppressor cell‐like population |
4 |
|
health knowledge, attitudes, practice |
4 |
|
herba epimedii |
4 |
|
hif-1a |
4 |
|
hif-1α |
4 |
|
highly active antiretroviral therapy |
4 |
|
hippocampus |
4 |
|
hmg |
4 |
|
homocysteine |
4 |
|
homocysteine - toxicity |
4 |
|
homozygous a° thal |
4 |
|
hormonal profile |
4 |
|
huanglian jiedu decoction |
4 |
|
human chorionic gonadotrophin |
4 |
|
human immunodeficiency virus |
4 |
|
hydrogen peroxide |
4 |
|
hypochlorous acid |
4 |
|
hypogonadotrophic hypogonadism |
4 |
|
hysterectomy |
4 |
|
icsi |
4 |
|
immunofluorescence |
4 |
|
immunologic factors - pharmacology |
4 |
|
in vitro fertilisation |
4 |
|
in vitro maturation |
4 |
|
in vivo imaging |
4 |
|
in-law conflict |
4 |
|
in-vitro fertilisation |
4 |
|
infertility - blood - diagnosis - therapy |
4 |
|
infertility, female - genetics |
4 |
|
infertility, female - therapy |
4 |
|
infertility, male |
4 |
|
inflammation - drug therapy - metabolism |
4 |
|
inhibin b |
4 |
|
inhibins - blood |
4 |
|
insemination, artificial - methods |
4 |
|
insulin |
4 |
|
interleukin-17 |
4 |
|
intimate partner violence, |
4 |
|
intrauterine devices, medicated |
4 |
|
intrauterine insemination |
4 |
|
intrauterine lidocaine |
4 |
|
ischemia reperfusion injury |
4 |
|
isolated polycystic ovaries |
4 |
|
isolation |
4 |
|
ivf-embryo transfer |
4 |
|
kidney - chemistry |
4 |
|
knee pain |
4 |
|
laparoscopy |
4 |
|
laser |
4 |
|
lef1 |
4 |
|
leptin |
4 |
|
letrozole pretreatment |
4 |
|
levonorgestrel intrauterine system |
4 |
|
lidocaine gel |
4 |
|
lignans - pharmacology |
4 |
|
literature review |
4 |
|
live birth |
4 |
|
live-birth |
4 |
|
liver |
4 |
|
lps |
4 |
|
lupus nephritis |
4 |
|
luteal phase |
4 |
|
luteal phase support |
4 |